郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.

期刊：Bioorganic & medicinal chemistry发表年份：2016作者：Andreas Brunschweiger; Pierre Koch; Miriam Schlenk; Muhammad Rafehi; Hamid Radjainia; Petra Küppers; Sonja Hinz; Felipe Pineda; Michael Wiese; Jörg Hockemeyer; Jag Heer; Frédéric Denonne; Christa E Müller
阅读更多 →

药效评价Novel approach of fragment-based lead discovery applied to renin inhibitors.

期刊：Bioorganic & medicinal chemistry发表年份：2016作者：Michiko Tawada; Shinkichi Suzuki; Yasuhiro Imaeda; Hideyuki Oki; Gyorgy Snell; Craig A Behnke; Mitsuyo Kondo; Naoki Tarui; Toshimasa Tanaka; Takanobu Kuroita; Masaki Tomimoto
阅读更多 →

药效评价Upregulation of MKP-7 in response to rosiglitazone treatment ameliorates lipopolysaccharide-induced destabilization of SIRT1 by inactivating JNK.

期刊：Pharmacological research发表年份：2016作者：Jung Seok Hwang; Sun Ah Ham; Taesik Yoo; Won Jin Lee; Kyung Shin Paek; Jae-Hwan Kim; Chi-Ho Lee; Han Geuk Seo
阅读更多 →

药效评价Systems-biology dissection of mechanisms and chemical basis of herbal formula in treating chronic myocardial ischemia.

期刊：Pharmacological research发表年份：2016作者：Shuzhen Guo; Peng Li; Bangze Fu; Wenjing Chuo; Kuo Gao; Wuxia Zhang; Junyao Wang; Jianxin Chen; Wei Wang
阅读更多 →